We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
Cap. Flow
+$224M
Cap. Flow %
0.26%
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$72.5M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$54.4M
3
BX icon
Blackstone
BX
+$44M
4
ABNB icon
Airbnb
ABNB
+$37.4M
5
EG icon
Everest Group
EG
+$30.9M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.8M
2
LSI
Life Storage, Inc.
LSI
+$39.6M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$23.8M
4
IGF icon
iShares Global Infrastructure ETF
IGF
+$19.2M
5
PDCE
PDC Energy, Inc.
PDCE
+$18.4M

Sector Composition

Rank Sector Weight
1 Technology 26.73%
2 Healthcare 12.76%
3 Financials 12.67%
4 Consumer Discretionary 11.16%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDTX icon
3751
Black Diamond Therapeutics
BDTX
$112M
$1.29K ﹤0.01%
449
– –
BZFD icon
3752
BuzzFeed
BZFD
$96.7M
$1.28K ﹤0.01%
839
– –
AIRG icon
3753
Airgain
AIRG
$72.4M
$1.26K ﹤0.01%
343
– –
RGS icon
3754
Regis Corp
RGS
$70.2M
$1.2K ﹤0.01%
85
– –
GROW icon
3755
US Global Investors
GROW
$38.5M
$1.19K ﹤0.01%
417
– –
LXEH
3756
Lixiang Education Holding
LXEH
$3.28M
$1.19K ﹤0.01%
22
– –
UP icon
3757
Wheels Up
UP
$198M
$1.17K ﹤0.01%
28
-105
-79% -$4.23K
LYRA
3758
DELISTED
LYRA THERAPEUTICS INC
LYRA
$1.16K ﹤0.01%
6
– –
CRVS icon
3759
Corvus Pharmaceuticals
CRVS
$1.17B
$1.15K ﹤0.01%
791
– –
BRLT icon
3760
Brilliant Earth
BRLT
$21.6M
$1.14K ﹤0.01%
386
– –
AXR icon
3761
AMREP Corp
AXR
$119M
$1.11K ﹤0.01%
66
– –
ORTX
3762
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1.1K ﹤0.01%
142
– –
BDRX
3763
Biodexa Pharmaceuticals
BDRX
$1.58M
– –
0
– –
MOLN
3764
Molecular Partners
MOLN
$1.07K ﹤0.01%
269
– –
MHH icon
3765
Mastech Digital
MHH
$93.2M
$1.06K ﹤0.01%
118
– –
MF
3766
DELISTED
Missfresh Limited American Depositary Shares
MF
$1.05K ﹤0.01%
1,151
+550
+92% +$526
LIDR icon
3767
AEye
LIDR
$61.1M
$1.03K ﹤0.01%
164
-719
-81% -$5.77K
CODX
3768
Co-Diagnostics
CODX
$5.6M
$1.03K ﹤0.01%
32
– –
ZYNE
3769
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$1.02K ﹤0.01%
805
– –
DCBO
3770
Docebo
DCBO
$566M
$1.01K ﹤0.01%
25
– –
HBM icon
3771
Hudbay
HBM
$12.3B
$998 ﹤0.01%
205
+170
+486% +$862
TIL icon
3772
Instil Bio
TIL
$50.3M
$980 ﹤0.01%
115
-428
-79% -$4.31K
CLSD
3773
DELISTED
Clearside Biomedical
CLSD
$950 ﹤0.01%
73
– –
CRIS icon
3774
Curis
CRIS
$7.83M
$948 ﹤0.01%
7
– –
ATER icon
3775
Aterian
ATER
$5.37M
$943 ﹤0.01%
240
-412
-63% -$2.13K
149 150
151
152 153

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
  • RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
  • RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
  • RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
  • RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.